Asthma in the EU: Towards better management and regulation of a public health issue (http://www.summitforchange.eu/media.php)

Excerpts from June 2007 European Respiratory Journal

Excerpts from May 2007 European Respiratory Journal

IPCRG/EFA European Campaign for allergic and respiratory diseases in FP7

The Global Burden of COPD: An International Call to Action
(PDF document)
Chronic Obstructive Pulmonary Disease (COPD) is a fatal lung disease characterised by progressive and irreversible airflow limitation. Every hour, COPD is estimated to kill over 250 people worldwide and the annual death rate from the disease is greater than that of lung cancer and breast cancer combined. Morbidity and mortality from COPD are considerable, and increasing. By the year 2020, COPD is predicted to become the third leading cause of death worldwide (exceeded only by heart disease and stroke). The Global Burden of COPD Summit (chaired by Professor Leonardo Fabbri MD, Modena, Italy) was convened to raise awareness and increase efforts to address the growing impact COPD is set to have on global health.

EMEA guidance on paediatric pharmacovigilance
(Word document)
IPCRG (International Primary Care Respiratory Group) and EFA (European Federation of Allergy and Airway Diseases Patients' Associations) welcome the recent adoption of the European Medicines Agency's (EMEA) "Guideline on conduct of pharmacovigilance for medicines used by the paediatric population", after having submitted comments to the draft guideline in an open consultation earlier this year.